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ABSTRACT 
A common form of arthritis in the elderly, being a major cause of localised pain and functional disability is Sandhigata Vata. This osteoarticular 
disorder  when confined to the knee is termed as Janusandhigata vata. The clinical manifestations  of Sandhigata Vata simulate the condition of 
degenerative  joint  disorder.  The  reported  prevalence  of  Osteoarthritis  from  a  study  in  rural  India  is  5.78%.  Leech  therapy  has  been  practiced 
successfully in musculoskeletal diseases in Ayurveda and other systems of medicine like Unani. It has also become the area of curiosity and interest 
in the research world. This study was intended to find out the effect of Jaloukavacharana in Janusandhigata Vata. Screening of patients suffering from 
Janusandhigata Vata was done at arthritis camps and finally 30 patients who fulfilled all necessary criteria and gave a written consent for the clinical 
trial were enrolled for the trial as study volunteers. It was a single centre, Repeated Measures study design with single sitting of Jaloukavacharana 
followed up for a period of 4 weeks (1
st day, 7
th day, 14
th day and 28
th day). Concurrent analgesics/NSAIDs and steroids in any form were not 
allowed. Lifestyle and /or dietary restrictions were not imposed. Pain, crepitus and modified WOMAC were the primary efficacy variables. Pain and 
WOMAC showed significant improvement (P<0.001, ANOVA) after treatment.   Crepitus remained unchanged after treatment. The study showed 
remarkable improvement in symptoms like pain, stiffness and functional ability of knee joint /joints. 
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INTRODUCTION 
Sandhigata  Vata  a  vedana  pradhana  Vata  Vyadhi    is  a 
joint disorder clinically characterized by features like pain 
which  is  aggravated  on    movements,  swelling  in  the 
affected  joint,    joint  stiffness
1  and  joint  crepitus
2.  The 
clinical  manifestations  of  Sandhigata  Vata  simulate  the 
condition  of  degenerative  joint  disorder,  which  is 
described  as  a  pain  predominant  disabling  form  of 
Arthritis with a strong association with ageing. 
According to World Health Organisation osteoarthritis is 
considered to be the second commonest musculoskeletal 
problem in the world population (30%). There is a steady 
rise in the prevalence of osteoarthritis from age 30 such 
that  by  65,  80%  of  the  population  have  radiological 
evidence,  though  only  25-30%  is  symptomatic
3.  The 
reported prevalence of osteoarthritis from a study in rural 
India is 5.78%. Indians are said to have increased knee 
osteoarthritis  (OA),  especially  amongst  women.  The 
major  risk  factors  associated  with  knee  OA  seen  in  a 
population  study  were:  age,  female  sex,  obesity, 
occupational  knee  bending,  physical  labour  and 
chondrocalcinosis
4.  The  therapeutic  approach  in 
conventional  medicine  ranges  from  oral/parental  non 
steroidal anti inflammatory drugs, intra articular steroids 
at  one  end,  to  the  more  technical  joint  replacement 
therapies at the other end. But every intervention has a 
limitation like that of adverse drug effects, expensiveness 
of  the  procedure  or  invasive  complications.  Therefore 
there is a need to develop a suitable treatment to control 
the problem preferably by non pharmacological measures. 
Hence  it  was  planned  to  conduct  a  clinical  study  to 
evaluate  the  efficacy  of  Jaloukavacharana  in 
Janusandhigata Vata. 
 
MATERIALS AND METHODS 
Key material for study  
Jalouka-  Procured  from  a  specimen  collector  and  were 
confirmed to be non poisonous. They were preserved in 
clean  containers  with  water,  by  changing  the  water  at 
regular intervals. 
 
Method of study 
Screening of patients suffering from Janusandhigata Vata 
was done at arthritis camps and finally 30 patients who 
fulfilled all necessary criteria and gave a written consent 
for the clinical trial were enrolled for the trial as study 
volunteers.  The  selection  was  done  at  random,  but 
irrespective  of  gender,  occupation,  educational  status, 
socio  economical  status  considerations.  They  were 
subjected to a Repeated Measures clinical study. Blinding 
was not possible, as the clinical trial involved a procedure 
which  was  to  be  explained  to  the  volunteer  before 
conducting  the  trial  and  the  volunteer  would  be  eye 
witnessing the same when the treatment was done. Study 
was  carried  out  as  per  the  Ethical  clearance  number: 
SDMCAU/ ACA15/ EC11/ 09-10 
 
Study duration  
Intervention was done for one sitting. Clinical assessment 
was done at baseline, immediate after treatment, 7
th, 14
th, 
and  28
th  days  of  treatment.  Total  study  duration  was  4 
weeks. 
 
Diagnostic criteria  
·  Pain  in  knee  joint  with/without  other  features  like 
stiffness, swelling and joint crepitus 
·  Evidence of radiological changes  of osteoarthritis of 
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Inclusion criteria 
·  Patients fulfilling the diagnostic criteria 
·  Patients of either sex with age 80 years and below 
·  Both  fresh  and  already  treated  cases  (with  no 
treatment response of earlier treatment) 
·  Patients who agreed to sign the informed consent form 
and follow up the protocol 
 
Exclusion criteria 
·  Patients suffering from  other forms of arthritis 
·  Janusandhigata  Vata  as  a  consequence  of  Abhigata 
and Bhagna 
·  Patients suffering from systemic illness which would 
decline  the  general  condition  of  the  patient  and 
interfere with the clinical trial  
·  Patients unfit for Raktmokshana 
·  Vulnerable group like lactating mothers, pregnant and 
mentally challenged persons 
 
 
 
Specific investigations  
·  X-ray  knee  antero  posterior  view  and  lateral  view 
before  treatment  to  know  the  extent  of  radiological 
changes before commencing the intervention.  
·  Clotting time and bleeding time  before commencing 
the intervention. 
 
Intervention (Method of Jaloukavacharana)   
Preparation phase  
Preparation  of  Jalouka:  The  jaloukas  were  removed 
from the preservation container and put in turmeric water 
until they became active. They were then transferred to a 
steel bowl containing clean water and were ready for use. 
 
Preparation  of  patient:  The  patient  was  clearly 
explained  about  the  procedure  and  the  treatment  was 
started  only  after  he/she  was  convinced  about  the 
treatment and gave a written consent. Above mentioned 
specific investigations were done apart from the routine 
investigations.
Table 1: Demographic profile of 30 patients 
 
Demographic character  Number of patients  Percentage 
Age in years 
41-50 
51-60 
61-70 
71 -80 
Gender 
Male 
Female 
Nature of work 
Sedentary work 
Physical work 
Household activities 
 
04 
11 
11 
04 
 
07 
23 
 
07 
14 
09 
 
13.33% 
36.67% 
36.67% 
13.33% 
 
23.33% 
76.67% 
 
23.33% 
46.67% 
30% 
 
Table 2: Comparison of Efficacy Measures at 1
st day, 7
th day, 14
th day and 28
th day of treatment from baseline (Mean difference and 
Standard Error) 
 
Variable  1
st day after treatment  7
th day after treatment  14
th day after treatment  28
th day after treatment 
MD+SE  P value  MD+SE  P value  MD+SE  P value  MD+SE  P value 
Pain  1.80+.10  <0.001  1.83+.08  <0.001  1.70+.09  <0.001  1.37+.13  <0.001 
WOMAC Pain  5.40+.28  <0.001  5.47+.29  <0.001  4.87+.31  <0.001  4.00+.42  <0.001 
WOMAC Stiffness  1.90+.15  <0.001  2.07+.14  <0.001  1.70+.21  <0.001  1.43+.23  <0.001 
WOMAC Difficulty  17.00+.53  <0.001  17.03+.77  <0.001  15.53+1.12  <0.001  12.93+1.17  <0.001 
WOMAC Combined  23.79+.64  <0.001  23.97+1.00  <0.001  21.41+1.59  <0.001  18.21+1.74  <0.001 
 
 
 
1=baseline, 2= 1
st day after treatment, 3= 7
th day after treatment, 
4= 14
th day after treatment, 5=28
th day after treatment. 
 
Graph 1: Mean pain over 4 weeks 
 
 
 
1= baseline,   2 = 1
st day after treatment,   3 = 7
th day after treatment, 
4 = 14
th day after treatment, 5 = 28
th day after treatment. 
 
Graph 2: Mean WOMAC total score over 4 weeks 
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Main procedure  
A  single  sitting  of  Jaloukavacharana  using  two  leeches 
per knee joint, one on medial aspect and one on lateral 
aspect of index knee joint/joints were carried out. When 
the leech got attached to the skin surface of the knee and 
started to suck the blood, a piece of cotton dipped in water 
was applied over the leech. The leech was allowed to suck 
from the area as long as it sucked and was allowed to get 
detached on its own. 
 
After procedure  
In  Patient:  The  area  of  bite  was  dusted  with  turmeric 
powder and the oozing blood was moped off with sterile 
gauze. When the bleeding was reduced, a loose bandage 
was tied around the knee to absorb the blood flowing out, 
so as to avoid inconvenience to the patient by the oozing 
blood. 
 
In  Jalouka:  The  leeches  were  immediately  induced 
emesis  by  applying  salt  at  their  mouth  end  and  then 
squeezing them from lower end to upper end, so that the 
blood  sucked  was  expelled  out.  Later  the  leeches  were 
washed in fresh water and transferred into clean patient 
name labelled containers containing fresh water. 
 
Assessment criteria  
Clinical evaluation was done  at each  visit to assess the 
efficacy variables pain (knee function assessment chart of 
the  British  Orthopaedic  Association  Research 
subcommittee)  and  crepitus  (Criteria  of  Altman  for  the 
diagnosis  of  idiopathic  Osteo  Arthritis  of  Knee  using 
clinical & X-Ray data). Patients completed the WOMAC
5 
[Western  Ontario  Mac  mister  index]  at  all  visits. 
Assessment was done on 0
th, 1
st, 7
th, 14
th, and 28
th days of 
the study period.  
 
RESULTS 
The  pre  and  post  treatment  scores  of  the  assessment 
criteria were tabulated and statistically analyzed by using 
repeated measures ANOVA. Pain and WOMAC showed 
remarkable  clinical  improvement  and  the  same  was 
supported by statistical analysis. These efficacy variables 
showed  highly  significant  difference  from  baseline 
measures at all time points (p<0.001). Table 2 shows the 
mean difference and standard error of efficacy variables 
from  baseline  to  1
st,  7
th,  14
th,  and  28
th  days  after 
intervention. There was a rapid decline in the mean value 
of pain and WOMAC (pain, stiffness, physical function 
difficulty  and  combined)  immediately  after  treatment 
which followed a plateau effect there by. Graph 1 shows 
the  mean  efficacy  of  the  therapy  on  pain  and  Graph  2 
shows  the  mean  efficacy  of  the  therapy  on  WOMAC 
(combined) at the evaluating time points.  
Clinically joint crepitus was appreciated in all patients. It 
remained unchanged throughout the study period. Hence 
data was not subjected to statistical analysis.  
 
DISCUSSION 
Demographic distribution of 30 patients 
The distribution of 30 patients according to age, gender 
and occupation is shown in table 1. It was observed that 
11 (36.67%) patients each belonged to age group of 51-60 
and  61-70.  Considering  gender,  23  out  of  30  were 
females.  Among  23  females,  19  (82.60%)  females  had 
reached menopause.  
Symptomatic  and  radiographic  OA  increases  with  age. 
The age related increase is more in females. The disease 
is  more  severe  in  females  with  more  symptoms,  more 
extensive involvement, and increased prevalence of knee
6.  
Considering occupation influence, more physical activity 
in  the  individual  and  house  hold  activities  in  females 
showed  a  relationship  in  the  manifestation  and 
aggravation  of  this  condition.  Epidemiological  surveys 
suggest that physical factors involved in occupations are 
important determinants of the condition
7.   
 
Jaloukavacharana  
The effectiveness of the treatment may be attributed to the 
analgesic,  anti-inflammatory  and  anaesthetic  activity  of 
the  leech  saliva  which  contains  a  number  of 
pharmacologically  active  biological  substances  like 
hirudin,  hyalorunidase,  inhibitors  of  kallikerine, 
fibrinases, collagenase etc. These substances are injected 
via leech into the body during the bite which brings about 
the effect
8.  
 
Adverse events 
No  major  adverse  events  were  observed  in  the 
intervention.  06  patients  (20  %)  complained  of  mild 
itching around the biten area on the third and fourth day 
after application of leech which reduced and disappeared 
on dusting the bite area with turmeric powder. No oral 
medicine was given for this purpose. 
 
CONCLUSION 
In this study it was observed that Jaloukavacharana had 
significant  improvement  on  pain,  and  WOMAC  in 
Janusandhigata  Vata.  But  there  was  no  change  in  joint 
crepitus. The therapy was found safe for practice. It was 
accepted as well as tolerated by patients. No obnoxious 
side effects were observed except for a mild local itching 
in few patients. The overall compliance to the therapy was 
good. Thus it can be concluded that leech therapy is an 
effective and safe treatment in symptomatic management 
of Janusandhigata Vata. 
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